22.418 articles found

New compounds, process for their preparation, intermediates, pharmaceutical compositions and their use in the treatment of 5-HT6 mediated disorders such as alzheimer s desease, cognitive disorders, co

GUNNAR NORDVALL, FERNANDO SEHGELMEBLE.

· 2006-07-03

Epidemiological assessment of levodopa use in Cuba: 1993-1998.

Lara G, Cuadrado-Gamarra JI, de Pedro-Cuesta J, Esteban EM, Giménez-Roldán S, Luis-González S.

Pharmacoepidemiol Drug Saf · 2006-07-01

DOI: 10.1002/pds.1150PMID: 16200653

Sleep complaints and their relation with drug treatment in patients suffering from Parkinson's disease.

Gómez-Esteban JC, Zarranz JJ, Lezcano E, Velasco F, Ciordia R, Rouco I, Losada J, Bilbao I.

Mov Disord · 2006-07-01

DOI: 10.1002/mds.20874PMID: 16602112

The levodopa wearing-off phenomenon in Parkinson's disease: pharmacokinetic considerations.

Stocchi F.

Expert Opin Pharmacother · 2006-07-01

DOI: 10.1517/14656566.7.10.1399PMID: 16805724

Diagnosis and treatment of Parkinson disease: molecules to medicine.

Savitt JM, Dawson VL, Dawson TM.

J Clin Invest · 2006-07-01

DOI: 10.1172/jci29178PMID: 16823471

Long-duration response to levodopa in patients with advanced Parkinson disease treated with subthalamic deep brain stimulation.

Wider C, Russmann H, Villemure JG, Robert B, Bogousslavsky J, Burkhard PR, Vingerhoets FJ.

Arch Neurol · 2006-07-01

DOI: 10.1001/archneur.63.7.951PMID: 16831963

[Levodopa and cognitive disorders in Parkinson's disease].

Leiva-Santana C, Alvarez-Saúco M.

Rev Neurol · 2006-07-01

DOI: 10.33588/rn.4302.2005571PMID: 16838257

Long-term follow-up (24 months) of quetiapine treatment in drug-induced Parkinson disease psychosis.

Klein C, Prokhorov T, Miniovich A, Dobronevsky E, Rabey JM.

Clin Neuropharmacol · 2006-07-01

DOI: 10.1097/01.wnf.0000228176.98582.93PMID: 16855423

Correlation between the Overactive Bladder questionnaire (OAB-q) and urodynamic data of Parkinson disease patients affected by neurogenic detrusor overactivity during antimuscarinic treatment.

Palleschi G, Pastore AL, Stocchi F, Bova G, Inghilleri M, Sigala S, Carbone A.

Clin Neuropharmacol · 2006-07-01

DOI: 10.1097/01.wnf.0000228177.75711.0fPMID: 16855424

An update on the treatment of Parkinson's disease.

Jankovic J.

Mt Sinai J Med · 2006-07-01

PMID: 16878274

Apomorphine in dopaminergic therapy.

Subramony JA.

Mol Pharm · 2006-07-01

DOI: 10.1021/mp060012cPMID: 16889431

Parkinson disease. Changing concepts and treatments.

Mendis T.

Can Fam Physician · 2006-07-01

PMID: 16893139